Related Experiment Video
Updated: Apr 19, 2026
04:45
Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
369
SOD1 Function and Its Implications for Amyotrophic Lateral Sclerosis Pathology: New and Renascent Themes
Rosie K A Bunton-Stasyshyn1, Rachele A Saccon1, Pietro Fratta1
1Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK.
Summary
Mutations in superoxide dismutase 1 (SOD1) cause amyotrophic lateral sclerosis (ALS). New research reveals SOD1
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Superoxide dismutase 1 (SOD1) is an antioxidant enzyme.
- Mutations in SOD1 are linked to amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease.
- The exact toxic mechanism of mutated SOD1 in ALS remains unclear.
Purpose of the Study:
- To explore novel functions of SOD1 beyond its antioxidant role.
- To investigate the implications of SOD1 mutations in neurodegeneration.
- To understand how SOD1 alterations contribute to ALS pathogenesis.
Main Methods:
- Review of recent findings on SOD1.
- Analysis of SOD1's involvement in cellular signaling pathways.
- Examination of SOD1's interaction with RNA molecules.
Main Results:
- SOD1 appears to have roles beyond antioxidant defense, including glucose signaling modulation (in yeast) and RNA binding.
- Single amino acid changes in SOD1 can lead to neurodegeneration.
- Multiple cellular systems are implicated in SOD1-related disease.
Conclusions:
- SOD1's functions are more diverse than previously understood.
- Understanding these novel functions is crucial for elucidating ALS pathogenesis.
- Further research into SOD1's roles may reveal new therapeutic targets for ALS.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
6
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
6
01:15Parkinson's Disease: Overview
2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
01:22Lysosomal Hydrolases
4.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
03:03Amyloid Fibrils
13.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
13.2K
01:23Alzheimer Disease ll: Pathophysiology
2
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
2
01:21Satellite Stem Cells and Muscular Dystrophy
2.6K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K